EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
MIT Technology Review·3d ago·5 min read
We’re still figuring out the side effects of GLP-1 weight-loss drugs
TL;DR
Recent research indicates that GLP-1 weight-loss drugs may reduce biological age in overweight and diabetic individuals, but they also come with notable side effects. While effective for weight loss and other health issues, the long-term impacts and potential risks are still being studied.
✦ Why It Matters
Consider monitoring ongoing research on GLP-1 drugs to stay informed about their benefits and risks.
Key Takeaways
- Stay updated on GLP-1 drug research for potential health impacts.
- Monitor side effects in patients using GLP-1 medications.
- Consider implications of GLP-1 use in pediatric populations.
- Evaluate the balance of benefits versus risks in prescribing GLP-1 drugs.
Full Summary
GLP-1 agonists, originally developed to treat diabetes and obesity, have shown promising results in reducing biological age by two to three years in overweight and diabetic patients compared to those on a placebo. These drugs suppress hunger and have been linked to various health benefits, including potential applications in treating substance-use disorders and neurodegenerative diseases.
However, they also carry side effects, primarily gastrointestinal issues like nausea and diarrhea, and more serious concerns such as pancreatitis and gallstone disease. Recent studies have raised alarms about possible nerve damage leading to vision loss and an increased risk of hair loss and nail disorders among users.
As prescriptions for GLP-1 drugs rise, especially among children, the World Health Organization has advised against their use in young patients due to insufficient evidence on safety and efficacy.